A team of researchers at McMaster University is working on an inhaled COVID-19 vaccine that offers better protection and is less costly to produce, store and ship.
We need more than drug discovery and development — we need social scientists, policy makers, communicators, economists and more — to solve the problem of antimicrobial resistance, experts at the AMR symposium said.
The discovery shows that the mechanisms of antimicrobial resistance (AMR) are more complex and highly evolved than scientists had previously recognized.